
India Tightens Oversight on GLP-1 Drugs Amid Rising Misuse Concerns
April 2, 2026
The Government of India has issued a comprehensive advisory on GLP-1 drugs, cautioning against their inappropriate use while acknowledging their growing role in managing type 2 diabetes and obesity. With demand surging—particularly for weight loss—authorities are stepping up regulation to






